glp-1 news today 2025-10-16 Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss GLP-1 Agonists: Using Semaglutide, Tirzepatide,

The next, phase 1b clinical trial in adults with T2DM compared once weekly retatrutide (0.5, 1.5, 3, 3 mg starting dose increased to 6, 3 mg starting dose increased to 12 mg) versus placebo versus dulaglutide 1.5 mg over 12 weeks [63]

Semaglutide drives the caloric deficit and fat loss

Metabolomic biomarkers in polycystic ovary syndrome: a review of the evidence

That scale gives the paper visibility and makes it harder to dismiss, even if the final message remains cautious

Rosenstock J et a l., 2023

To decide whether a lip flip is the right procedure for you, its helpful to see pictures of real people before and after the Botox injections